Objective: This study aims to understand the current teaching of menopause medicine in American obstetrics and gynecology residency programs.
Methods: A Web-based survey was e-mailed to all American obstetrics and gynecology residency directors, with a request that they forward it to their residents.
Results: Of 258 residency program directors contacted, 79 (30.6%) confirmed forwarding the survey. In all, 1,799 people received the survey, with 510 completions, for a response rate of 28.3%. Most residents reported that they had limited knowledge and needed to learn more about these aspects of menopause medicine: pathophysiology of menopause symptoms (67.1%), hormone therapy (68.1%), nonhormone therapy (79.0%), bone health (66.1%), cardiovascular disease (71.7%), and metabolic syndrome (69.5%). Among fourth-year residents who will be entering clinical practice soon, a large proportion also reported a need to learn more in these areas: pathophysiology of menopause symptoms (45.9%), hormone therapy (54.2%), nonhormone therapy (69.4%), bone health (54.2%), cardiovascular disease (64.3%), and metabolic syndrome (63.8%). When asked to rate the most preferred modalities for learning about menopause, the top choice was supervised clinics (53.2%), followed by case presentations (22.2%), formal lectures (21.3%), small groups (14.7%), Web-based learning (7.8%), and independent reading (5.2%). Only 20.8% of residents reported that their program had a formal menopause medicine learning curriculum, and 16.3% had a defined menopause clinic as part of their residency.
Conclusions: It seems that some American residency programs do not fulfill the educational goals of their residents in menopause medicine. A curriculum would be beneficial for increasing knowledge and clinical experience on menopause issues.
From the 1Division of Reproductive Endocrinology, Department of Gynecology and Obstetrics, Johns Hopkins University School of Medicine, Lutherville, MD; 2Department of Gynecology and Obstetrics, Johns Hopkins University School of Medicine, Baltimore, MD; 3Department of Gynecology and Obstetrics, Johns Hopkins Bayview Medical Center, Baltimore, MD; and 4Johns Hopkins Bloomberg School of Public Health, Baltimore, MD.
Received November 21, 2012; revised and accepted February 12, 2013.
Financial disclosure/conflicts of interest: None reported.
Address correspondence to: Mindy S. Christianson, MD, Division of Reproductive Endocrinology, Department of Gynecology and Obstetrics, Johns Hopkins University School of Medicine, Falls Concourse, Suite 280, 10751 Falls Road, Lutherville, MD 20193. E-mail: email@example.com